Usselman Charlotte W, Nielson Chantelle A, Luchyshyn Torri A, Gimon Tamara I, Coverdale Nicole S, Van Uum Stan H M, Shoemaker J Kevin
Neurovascular Research Laboratory, School of Kinesiology, Western University, London, Ontario, Canada.
Department of Medicine, Western University, London, Ontario, Canada.
Am J Physiol Regul Integr Comp Physiol. 2016 Nov 1;311(5):R957-R963. doi: 10.1152/ajpregu.00190.2016. Epub 2016 Oct 12.
We tested the hypothesis that sympathetic responses to baroreceptor unloading may be affected by circulating sex hormones. During lower body negative pressure at -30, -60, and -80 mmHg, muscle sympathetic nerve activity (MSNA), heart rate, and blood pressure were recorded in women who were taking (n = 8) or not taking (n = 9) hormonal contraceptives. All women were tested twice, once during the low-hormone phase (i.e., the early follicular phase of the menstrual cycle and the placebo phase of hormonal contraceptive use), and again during the high-hormone phase (i.e., the midluteal phase of the menstrual cycle and active phase of contraceptive use). During baroreceptor unloading, the reductions in stroke volume and resultant increases in MSNA and total peripheral resistance were greater in high-hormone than low-hormone phases in both groups. When normalized to the fall in stroke volume, increases in MSNA were no longer different between hormone phases. While stroke volume and sympathetic responses were similar between women taking and not taking hormonal contraceptives, mean arterial pressure was maintained during baroreceptor unloading in women not taking hormonal contraceptives but not in women using hormonal contraceptives. These data suggest that differences in sympathetic activation between hormone phases, as elicited by lower body negative pressure, are the result of hormonally mediated changes in the hemodynamic consequences of negative pressure, rather than centrally driven alterations to sympathetic regulation.
对压力感受器卸载的交感反应可能会受到循环性激素的影响。在-30、-60和-80 mmHg的下体负压期间,记录了正在服用(n = 8)或未服用(n = 9)激素避孕药的女性的肌肉交感神经活动(MSNA)、心率和血压。所有女性均接受了两次测试,一次是在低激素阶段(即月经周期的卵泡早期和激素避孕药使用的安慰剂阶段),另一次是在高激素阶段(即月经周期的黄体中期和避孕药使用的活跃阶段)。在压力感受器卸载期间,两组中高激素阶段的每搏输出量减少以及由此导致的MSNA和总外周阻力增加均大于低激素阶段。当将MSNA增加量与每搏输出量下降进行归一化处理后,激素阶段之间的MSNA增加量不再有差异。虽然服用和未服用激素避孕药的女性之间的每搏输出量和交感反应相似,但在压力感受器卸载期间,未服用激素避孕药的女性能够维持平均动脉压,而使用激素避孕药的女性则不能。这些数据表明,下体负压引起的激素阶段之间交感激活的差异,是激素介导的负压血流动力学后果变化的结果,而非交感神经调节的中枢驱动改变。